These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27119236)

  • 21. Prognostic value of systemic immune inflammation index and geriatric nutrition risk index in early-onset colorectal cancer.
    Xiang S; Yang YX; Pan WJ; Li Y; Zhang JH; Gao Y; Liu S
    Front Nutr; 2023; 10():1134300. PubMed ID: 37143476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfur Metabolism of the Gut Microbiome and Colorectal Cancer: The Threat to the Younger Generation.
    Moon JY; Kye BH; Ko SH; Yoo RN
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Onset Colorectal Cancer in Arabs, Are We Dealing with a Distinct Disease?
    Al Zaabi A; Al Shehhi A; Sayed S; Al Adawi H; Al Faris F; Al Alyani O; Al Asmi M; Al-Mirza A; Panchatcharam S; Al-Shaibi M
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of a Six-Year Existing Screening Programme Using the Faecal Immunochemical Test in Flanders (Belgium) on Colorectal Cancer Incidence, Mortality and Survival: A Population-Based Study.
    Tran TN; Hoeck S; De Schutter H; Janssens S; Peeters M; Van Hal G
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of BRAF, Programmed Cell Death 1 (PD1), and PD Ligand 1 (PDL1) Protein Expression in Colon Adenocarcinoma.
    Ibrahiem AT; Eladl E; Toraih EA; Fawzy MS; Abdelwahab K; Elnaghi K; Emarah Z; Shaalan AAM; Ehab Z; Soliman NA
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early onset colorectal cancer: Challenges across the cancer care continuum.
    AlZaabi A; AlHarrasi A; AlMusalami A; AlMahyijari N; Al Hinai K; ALAdawi H; Al-Shamsi HO
    Ann Med Surg (Lond); 2022 Oct; 82():104453. PubMed ID: 36268309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer.
    Nakamura K; Hernández G; Sharma GG; Wada Y; Banwait JK; González N; Perea J; Balaguer F; Takamaru H; Saito Y; Toiyama Y; Kodera Y; Boland CR; Bujanda L; Quintero E; Goel A
    Gastroenterology; 2022 Nov; 163(5):1242-1251.e2. PubMed ID: 35850198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent Disparities in Colorectal Cancer Screening: A Tell-Tale Sign for Implementing New Guidelines in Younger Adults.
    Liu PH; Sanford NN; Liang PS; Singal AG; Murphy CC
    Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1701-1709. PubMed ID: 35765830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nomogram Predicting the Survival of Young-Onset Patients with Colorectal Cancer Liver Metastases.
    Cheng X; Li Y; Chen D; Xu X; Liu F; Zhao F
    Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Black Panther, Masculinity Barriers to Medical Care, and Colorectal Cancer Screening Intention Among Unscreened American Indian/Alaska Native, Black, and White Men.
    Brooks E; Islam JY; Perdue DG; Petersen E; Camacho-Rivera M; Kennedy C; Rogers CR
    Front Public Health; 2022; 10():814596. PubMed ID: 35462819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Long-Term and Large-Scale Real-World Study in Taiwan: Efficacy of Target Therapy in Stage IV Colorectal Cancer.
    Huang SC; Lin CC; Teng HW; Lin HH; Chang SC; Lan YT; Wang HS; Yang SH; Chen WS; Jiang JK
    Front Oncol; 2022; 12():808808. PubMed ID: 35372058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cause, Epidemiology, and Histology of Polyps and Pathways to Colorectal Cancer.
    Sullivan BA; Noujaim M; Roper J
    Gastrointest Endosc Clin N Am; 2022 Apr; 32(2):177-194. PubMed ID: 35361330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of TMED3 is independently associated with colorectal cancer prognosis.
    Wang RF; Hong YG; Hao LQ; Yu HT
    Exp Ther Med; 2022 Apr; 23(4):286. PubMed ID: 35317448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Masculinity Barriers to Ever Completing Colorectal Cancer Screening among American Indian/Alaska Native, Black, and White Men (Ages 45-75).
    Rogers CR; Perdue DG; Boucher K; Korous KM; Brooks E; Petersen E; Inadomi JM; Tuuhetaufa F; Levant RF; Paskett ED
    Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a Novel Aminocyclopropenone Compound That Inhibits BRD4-Driven Nucleoporin NUP210 Expression and Attenuates Colorectal Cancer Growth.
    Kondo H; Mishiro K; Iwashima Y; Qiu Y; Kobayashi A; Lim K; Domoto T; Minamoto T; Ogawa K; Kunishima M; Hazawa M; Wong RW
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases.
    Wada Y; Shimada M; Morine Y; Ikemoto T; Saito Y; Baba H; Mori M; Goel A
    Eur J Cancer; 2022 Mar; 163():66-76. PubMed ID: 35042069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of small nucleolar RNA SNORD1C is associated with unfavorable outcome in colorectal cancer.
    Liu Y; Zhao C; Sun J; Wang G; Ju S; Qian C; Wang X
    Bioengineered; 2021 Dec; 12(1):8943-8952. PubMed ID: 34702132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Updates, Controversies, and Emerging Approaches in Colorectal Screening.
    Wang T; Tsang T; Turshudzhyan A; Dacus H; Tadros M
    Cureus; 2021 Sep; 13(9):e17844. PubMed ID: 34660050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of immune-related subtypes of colorectal cancer to improve antitumor immunotherapy.
    Zheng X; Gao Y; Yu C; Fan G; Li P; Zhang M; Yu J; Xu M
    Sci Rep; 2021 Sep; 11(1):19432. PubMed ID: 34593914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Startup and implementation costs of a colorectal cancer screening tailored navigation research study.
    Bucho-Gonzalez J; Herman PM; Larkey L; Menon U; Szalacha L
    Eval Program Plann; 2021 Apr; 85():101907. PubMed ID: 33561756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.